Healthcare Sales & Marketing Network News: CHF

Searching News Database: CHF

HSMN NewsFeed - 11 May 2026
Partner Therapeutics Announces FDA Approval of BIZENGRI(R) (Zenocutuzumab-zbco) for NRG1 Fusion-Positive Cholangiocarcinoma Following Receipt of FDA Commissioner's National Priority Voucher
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 18 Sep 2024
Accord BioPharma, Inc. Announces U.S. Food & Drug Administration Approval of 420mg Strength of HERCESSI(TM) (trastuzumab-strf), a biosimilar to Herceptin(R) (trastuzumab), for the Treatment of Several Forms of HER2-Overexpressing Cancer
Biopharmaceuticals Generics Oncology FDA

HSMN NewsFeed - 15 Feb 2023
Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL
Diagnostics

HSMN NewsFeed - 14 Jun 2022
Anjarium Biosciences appoints Stephen Yoo, MD as Chief Executive Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 Mar 2022
Roche announces collaboration with Bristol Myers Squibb to advance personalised healthcare through digital pathology solutions
Diagnostics

HSMN NewsFeed - 15 Dec 2021
Roche Launches the First Infectious Disease Tests and Cobas Omni Utility Channel for Use on the Cobas 5800 System in Countries Accepting the CE Mark
Diagnostics Product Launch

HSMN NewsFeed - 8 Nov 2021
Azurity Pharmaceuticals, Inc. Announces FDA Approval of Eprontia(TM) (Topiramate) Oral Solution
Biopharmaceuticals Neurology FDA

HSMN NewsFeed - 13 Sep 2021
AbbVie and REGENXBIO Announce Eye Care Collaboration
Biopharmaceuticals Regenerative Medicine Ophthalmology

HSMN NewsFeed - 7 Jul 2021
Elekta optimizes treatment times for cancer patients via proactive service innovation
Devices Oncology

HSMN NewsFeed - 9 Mar 2021
Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer patients eligible for targeted treatment with LORBRENA (lorlatinib)
Diagnostics Oncology FDA

HSMN NewsFeed - 29 Oct 2020
Roche receives FDA approval for the cobas EGFR Mutation Test v2 as the first companion diagnostic test for expanded EGFR TKI therapies in patients with non-small cell lung cancer
Diagnostics Oncology FDA

HSMN NewsFeed - 17 Mar 2020
Roche begins shipments of first 400,000 COVID-19 tests to laboratories across US to begin patient testing under FDA Emergency Use Authorization
Diagnostics Product Launch

HSMN NewsFeed - 16 Sep 2019
BioVentrix Announces the Appointment of Pedro Marques as VP of Sales in Europe
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 12 Sep 2019
REDUCE FMR Study Shows Cardiac Dimensions' Carillon(R) System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure
Devices Interventional Cardiology

HSMN NewsFeed - 3 Sep 2019
Strekin AG Secures Financing to Complete Development of STR001 in Sudden Sensorineural Hearing Loss and to Prepare NDA Filing in Europe
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 6 Aug 2019
BioVentrix Announces Key Additions to Leadership Team
Devices Cardiology Personnel

HSMN NewsFeed - 12 Jun 2019
Sobi Acquires Emapalumab and Related Assets
Biopharmaceuticals Acquisitions

HSMN NewsFeed - 4 Jan 2019
Oculis Raises CHF15.5 Million in an Extension of its Series B Financing Round - Total Raised CHF35.5 Million
Biopharmaceuticals Ophthalmology Venture Capital

HSMN NewsFeed - 12 Dec 2018
Lilly and AC Immune Announce License and Collaboration Agreement
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 8 Oct 2018
CSA Medical Secures $23 Million to Advance its Cryospray(TM) Therapies for Esophageal Disease and COPD
Devices Venture Capital

HSMN NewsFeed - 21 Sep 2018
Lilly Receives Positive CHMP Opinion for Emgality(TM) (galcanezumab) for the Prophylaxis of Migraine in Adults
Biopharmaceuticals Neurology Regulatory

HSMN NewsFeed - 23 Aug 2018
Roche receives FDA approval for cobas EGFR Mutation Test v2 as companion diagnostic with IRESSA (gefitinib) in first-line treatment of patients with non-small cell lung cancer (NSCLC)
Diagnostics Oncology FDA

HSMN NewsFeed - 11 Jul 2018
FDA Accepts Biologics License Application For Subcutaneous Formulation Of Herceptin
Biopharmaceuticals Drug Delivery Oncology FDA

HSMN NewsFeed - 21 Jun 2018
Sera Prognostics Appoints Dr. Garrett K. Lam as Chief Medical Officer
Diagnostics OB/GYN Personnel

HSMN NewsFeed - 11 Jun 2018
Roche introduces first self-testing device for Warfarin monitoring with built in Bluetooth(R) technology
Devices Monitoring Product Launch

HSMN NewsFeed - 7 Jun 2018
SutroVax Announces $85M Series C Financing led by TPG Growth
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 29 May 2018
UCB Announces the Approval of CIMZIA(R) (certolizumab pegol) for Moderate-to-Severe Plaque Psoriasis, Representing an Important New Option for Patients in the U.S.
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 14 May 2018
FDA approves additional claim for Roche cobas Zika test
Diagnostics FDA

HSMN NewsFeed - 16 Apr 2018
Roche receives FDA clearance for cobas(R) CT/NG for cobas(R) 6800/8800 Systems
Diagnostics FDA

HSMN NewsFeed - 9 Mar 2018
CTI BioPharma Announces Publication of Pacritinib Phase 3 PERSIST-2 Clinical Trial in JAMA Oncology
Biopharmaceuticals Oncology

HSMN NewsFeed - 8 Mar 2018
Roche launches the new cobas m 511 analyzer, signaling a new era in hematology testing
Diagnostics FDA Product Launch

HSMN NewsFeed - 23 Feb 2018
VoCare Develops the World's First Mobile Professional Grade Medical Multi-Diagnostic Device, Which Provides a Revolutionary Integrated Mobile Point-of-Care Solution as Well as a Remote Patient Monitoring Solution
Devices Monitoring

HSMN NewsFeed - 29 Jan 2018
gammaCore(R) Receives FDA Clearance for the Acute Treatment of Pain Associated with Migraine Headache in Adult Patients
Devices Neurology FDA

HSMN NewsFeed - 4 Jan 2018
Oculis Raises CHF20 Million in a Series B Financing Round to Advance Breakthrough Treatments for Ophthalmic Diseases
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 11 Dec 2017
FDA Accepts Biologics License Application (BLA) to Review Galcanezumab for the Prevention of Migraine in Adults
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Nov 2017
Amgen Launches The ENBREL Mini(TM) Single-Dose Prefilled Cartridge With AutoTouch(TM) Reusable Autoinjector That Is Ergonomically Designed For Patients
Biopharmaceuticals Devices Drug Delivery Product Launch

HSMN NewsFeed - 6 Oct 2017
Intezyne Closes Oversubscribed $10M Series A Financing to Drive Rapid Oncology Portfolio Development
Biopharmaceuticals Oncology Venture Capital Personnel

HSMN NewsFeed - 8 Sep 2017
IHC 2017: Lilly's Galcanezumab Demonstrates Positive Long-Term Safety Results for up to 12 Months in Patients with Migraine
Biopharmaceutical Neurology

HSMN NewsFeed - 4 Aug 2017
Lilly Announces Positive Results for Second Phase 3 Study of Lasmiditan for the Acute Treatment of Migraine
Biopharmaceuticals Neurology

HSMN NewsFeed - 26 Jul 2017
Roche Launches the Avenio Millisect System for Precise and Efficient Dissection of Tissue Biopsies
Diagnostics Product Launch

HSMN NewsFeed - 1 Jun 2017
Roche announces FDA approval of companion diagnostic to identify ALK-positive non-small cell lung cancer patients
Diagnostics Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 17 May 2017
Sera Prognostics Appoints Nadia Altomare as Chief Commercial Officer
Diagnostics Personnel

HSMN NewsFeed - 12 May 2017
Lilly Announces Positive Results for Three Phase 3 Studies of Galcanezumab for the Prevention of Episodic and Chronic Migraine
Biopharmaceuticals Neurology

HSMN NewsFeed - 1 May 2017
FDA Clears Roche High-Volume Immunoassay Lab Testing Solution to Support Critical Medical Treatment Decisions
Diagnostics FDA

HSMN NewsFeed - 12 Apr 2017
Roche Launches Antibody Test to Aid in Diagnosis of Challenging Prostate Cancer Cases
Diagnostics Oncology Product Launch

HSMN NewsFeed - 30 Mar 2017
Symetis and Boston Scientific Reach USD 435 Million Purchase Agreement
Devices Interventional Cardiology Mergers & Acquisitions

HSMN NewsFeed - 3 Nov 2016
FDA Accepts Genentech's Biologics License Application For Subcutaneous Formulation Of Rituximab
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 17 Oct 2016
InspireMD Announces Independent Study Published in the Journal of Endovascular Therapy That Continues to Support the Clinical Benefit and Utility of the CGuard Embolic Prevention System
Devices Interventional

HSMN NewsFeed - 10 Oct 2016
First Positive Phase 3 Results in Adjuvant Setting for Renal Cell Carcinoma Show SUTENT(R) (sunitinib) Extended Disease Free Survival After Surgical Removal
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Sep 2016
Roche Receives 510(K) Clearance from FDA for Treponema Pallidum Assay to Aid Clinicians in the Diagnosis of Syphilis Infection
Diagnostics FDA

HSMN NewsFeed - 29 Aug 2016
Roche receives FDA Emergency Use Authorization for Zika PCR Test
Biopharmaceuticals FDA

HSMN NewsFeed - 25 May 2016
Roche announces the first FDA-approved CMV test for use in hematopoietic stem cell transplant recipients
Diagnostics FDA

HSMN NewsFeed - 13 May 2016
Impulse Dynamics Completes $30 Million Financing Round
Devices Cardiology Venture Capital

HSMN NewsFeed - 23 Mar 2016
Roche Submits Filing to FDA For cobas(R) Procalcitonin (Pct) Assay to Help Clinicians Assess Response of Septic Patients to Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 21 Mar 2016
FDA approves expanded use of Roche hepatitis C virus RNA test as aid in diagnosis
Diagnostics FDA

HSMN NewsFeed - 20 Jan 2016
Kuros Biosurgery Holding Ltd. Closes Merger With Cytos Biotechnology Ltd. Which is Renamed Kuros Biosciences Ltd.
Devices Regenerative Medicine Mergers & Acquisitions

HSMN NewsFeed - 23 Nov 2015
ObsEva Closes CHF 60 (USD 60) Million in Series B Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 Nov 2015
World's First Endovascular Neuromodulation Device Implanted in Man for the Treatment of Congestive Heart Failure
Devices Interventional Cardiology

HSMN NewsFeed - 23 Oct 2015
Sequana Medical AG Raises CHF 9 million (USD 9.3M) in a Series C Extension
Devices Venture Capital

HSMN NewsFeed - 10 Sep 2015
Metamark Genetics Appoints Kenneth E. Weg as President and Chief Executive Officer
Diagnostics Oncology Personnel

HSMN NewsFeed - 1 Sep 2015
CeQur Announces $100 Million Series C Financing
Devices Drug Delivery Endocrinology Venture Capital

HSMN NewsFeed - 7 Jul 2015
Diadexus, Inc. Names William Hammond as Vice President of Sales
Diagnostics Cardiology Personnel

HSMN NewsFeed - 7 Jul 2015
Allergan Enters Into Licensing Agreement with Merck to Obtain Exclusive Worldwide Rights to CGRP Migraine Development Program
Biopharmaceuticals Acquisitions Licensing

HSMN NewsFeed - 3 Jun 2015
Ardelyx to Raise $77.8 Million in a Private Placement and Announces New Product Candidate for the Treatment of Hyperkalemia to Begin Clinical Development in Mid-2015
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 26 May 2015
CVRx(R) Barostim Therapy(R) for Heart Failure Clinical Trial Results Presented in the Late-Breaking Clinical Trial Session of the Heart Rhythm Society 2015 Annual Conference
Devices Cardiology

HSMN NewsFeed - 2 Mar 2015
Boston Scientific Announces Definitive Agreement To Acquire American Medical Systems' Urology Portfolio For Up To $1.65 Billion
Devices Urology Mergers & Acquisitions

HSMN NewsFeed - 10 Feb 2015
Edwards Announces Board Changes
Devices Cardiology Personnel

HSMN NewsFeed - 30 Jan 2015
OSTAR Launches First Cellular TeleHealth Blood Pressure System for CHF
Devices Monitoring Product Launch

HSMN NewsFeed - 2 Dec 2014
Xeltis Closes EURO 27 Million / USD 34 Million Series B Financing
Devices Cardiology Venture Capital

HSMN NewsFeed - 11 Aug 2014
Auxilium Pharmaceuticals, Inc. Appoints Andrew Saik Chief Financial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 22 May 2014
Santhera Reports Positive Outcome for Catena(R)/Raxone(R) in Phase III DMD Trial Supported by Additional Respiratory Function Data
Biopharmaceuticals

HSMN NewsFeed - 21 Mar 2014
Cochlear Announces the FDA Approval and U.S. Launch of the First of Its Kind Cochlear(TM) Nucleus(R) Hybrid Implant System
Devices FDA Product Launch

HSMN NewsFeed - 12 Mar 2014
Novimmune Appoints Andrew J. Oakley as CFO
Biopharmaceuticals Personnel

HSMN NewsFeed - 3 Mar 2014
Myriad Publishes Clinical Utility Study for Prolaris(R)
Diagnostics Urology

HSMN NewsFeed - 29 Jan 2014
Myriad's Prolaris(R) Test Significantly Modifies Treatment Decisions for Patients With Prostate Cancer
Diagnostics Oncology

HSMN NewsFeed - 18 Oct 2013
ARIAD Announces Discontinuation of the Phase 3 Epic Trial of Iclusig in Patients with Newly Diagnosed Chronic Myeloid Leukemia
Biopharmaceuticals Oncology

HSMN NewsFeed - 18 Oct 2013
Cimzia(R) (Certolizumab Pegol) Approved by FDA for Treatment of Adults with Active Ankylosing Spondylitis
Biopharmaceuticals FDA

HSMN NewsFeed - 30 Sep 2013
Cimzia(R) (certolizumab pegol) approved by the U.S. FDA for treatment of adult patients with active psoriatic arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 2 Sep 2013
UK's NICE Final Appraisal Determination (FAD) Confirms Positive Recommendation for ThromboGenics' JETREA(R) for Treatment of Vitreomacular Traction and Macular Hole
Biopharmaceuticals Ophthalmology Regulatory Reimbursement

HSMN NewsFeed - 29 Aug 2013
ObsEva SA Announces CHF 32 Million Series A Funding From Leading Venture Capital Firms and a License Agreement With Merck Serono
Biopharmaceuticals Venture Capital Personnel

HSMN NewsFeed - 2 Aug 2013
Germany's IQWiG Confirms That ThromboGenics' JETREA(R) Demonstrates Major Added Value for the Treatment of Vitreomacular Traction and Macular Hole
Biopharmaceuticals Ophthalmology

HSMN NewsFeed - 25 Jun 2013
Multiplicom Appoints Dr. Ian Gilham as Chairman of the Board
Diagnostics Personnel

HSMN NewsFeed - 12 Jun 2013
ThromboGenics' JETREA(R) Receives Positive Initial NICE Recommendation for Vitreomacular Traction and Macular Hole
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 6 Jun 2013
Veran Medical Technologies Launches SPiNDrive(R) 2.0, as American College of Chest Physicians Recognizes This Technology in New Guidelines
Devices Oncology Product Launch

HSMN NewsFeed - 22 Mar 2013
FDA Approves GE Healthcare's AdreView(TM) (Iobenguane I 123 Injection) for Cardiac Risk Evaluation in Heart Failure Patients
Biopharmaceuticals Cardiology Radiology FDA

HSMN NewsFeed - 14 Mar 2013
EDAP Introduces Focal.One(R): A New Robotic HIFU Device for Focal Therapy of Prostate Cancer
Devices Oncology Product Launch

HSMN NewsFeed - 5 Mar 2013
Endosense Closes an Additional USD 4.3 Million/CHF 4 Million in Series C Financing
Devices Cardiology Venture Capital

HSMN NewsFeed - 1 Feb 2013
EDAP Submits U.S. FDA Pre-Market Approval Application for Ablatherm(R)-HIFU for Treatment of Low Risk, Localized Prostate Cancer
Devices Oncology FDA

HSMN NewsFeed - 18 Jan 2013
ThromboGenics Receives Positive CHMP Opinion for JETREA(R)
Biopharmaceuticals Ophthalmology Regulatory

HSMN NewsFeed - 12 Dec 2012
Galderma, World’s Leading Company Focused Exclusively on Dermatology, Acquires Spirig
Biopharmaceuticals Dermatology Mergers & Acquisitions

HSMN NewsFeed - 17 Oct 2012
SV Life Sciences and Third Rock Ventures Launch Transformative Medical Device Company Cibiem with $10 Million Series A
Devices Cardiology Venture Capital Personnel

HSMN NewsFeed - 25 Sep 2012
Life Technologies Launches Pervenio(TM) Lung RS, a Risk Stratification Test for Early Stage Lung Cancer
Diagnostics Oncology

HSMN NewsFeed - 15 Jun 2012
Saladax Biomedical, Inc. Appoints Kevin M. Harter as President and Chief Executive Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 8 Mar 2012
SensiVida Medical Technologies, Inc. Announces Appointment of Sidney Braginsky as Board Director
Devices Monitoring Personnel

HSMN NewsFeed - 27 Jan 2012
Saladax Biomedical, Inc. Announces the Resignation of Edward L. Erickson as President and Chief Executive Officer
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 15 Nov 2011
Sera Prognostics Secures $19.3 Million Series A Funding to Commercialize Preterm Birth Predictor; Appoints Gregory C. Critchfield, MD as Chief Executive Officer
Diagnostics Venture Capital Personnel

HSMN NewsFeed - 30 Jun 2011
Sorbent Therapeutics Completes $36 Million Series B Financing for Net of $53 Million
Biopharmaceuticals Cardiology Venture Capital Personnel

HSMN NewsFeed - 27 Apr 2011
Deep Breeze Introduces Breeze@home(TM) -- A New Telemonitoring Device to Improve COPD Assessment
Devices Monitoring

HSMN NewsFeed - 27 Apr 2011
Johnson & Johnson and Synthes Announce Definitive Merger Agreement to Create World's Most Innovative and Comprehensive Orthopaedics Business
Devices Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 4 Apr 2011
superDimension Receives FDA 510(k) Clearance for Marker Delivery Kit
Devices FDA

HSMN NewsFeed - 10 Mar 2011
Practice Guidelines Confirm Utility of Endoscopic Radiofrequency Ablation (RFA) for the Treatment of Barrett's Esophagus
Devices Gastroenterology

HSMN NewsFeed - 9 Feb 2011
Cayenne Medical, Inc. Appoints David B. Springer President & CEO
Devices Personnel

HSMN NewsFeed - 18 Jan 2011
Diagnoplex Closes an Extension of its Series A Financing With a Substantial Investment by Debiopharm Group(TM)
Diagnostics Personalized Medicine Venture Capital

HSMN NewsFeed - 12 Nov 2010
Delenex Therapeutics Secures CHF 13.5 Million Series A Venture Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 27 Sep 2010
Deep Breeze Launches Unique, Non-Invasive, Radiation-Free Emergency Department Pulmonary Imaging System in the U.S.
Devices

HSMN NewsFeed - 15 Sep 2010
Saladax Biomedical Adds Industry Expert to Board of Directors
Diagnostics Personalized Medicine Personnel

HSMN NewsFeed - 17 Aug 2010
STAAR Surgical Expands Leadership Team to Execute Company's Growth Strategy
Devices Ophthalmology Personnel

HSMN NewsFeed - 25 Jun 2010
Investigational BRINAVESS (vernakalant) for Infusion Recommended for Approval by the CHMP in the European Union (EU) for the Rapid Conversion of Recent Onset Atrial Fibrillation
Biopharmaceuticals Cardiology Regulatory

HSMN NewsFeed - 14 Jun 2010
Hemosphere, Inc., Names Patrick Wethington New CEO
Devices Personnel

HSMN NewsFeed - 11 May 2010
St. Jude Medical Announces European Launch of Industry's First Quadripolar Pacing System
Devices Cardiology

HSMN NewsFeed - 5 May 2010
New Studies Presented at Digestive Disease Week Highlight the Value of PillCam(R) Capsule Endoscopy
Devices Gastroenterology

HSMN NewsFeed - 23 Apr 2010
Clinical study demonstrates that Cardiola's m.pulse(R) system "immediately improves cardiac output under acute non-invasive Muscular CounterPulsation (MCP) treatment in patients with patients with stable CHF" (chronic heart failure)
Devices Cardiology

HSMN NewsFeed - 14 Apr 2010
Bioheart Commenced Successful Regenerative Stem Cell Treatments with Latin American Patients Having Congestive Heart Failure
Regenerative Medicine Cardiology

HSMN NewsFeed - 9 Apr 2010
Cephalon Completes Acquisition of Swiss Pharmaceutical Company Mepha
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 23 Feb 2010
Forest Laboratories Receives Decision from FDA for Supplemental New Drug Application for Bystolic(R)
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 11 Feb 2010
NovaShunt Starts its Pivotal Clinical Study "PIONEER" to Demonstrate the Clinical Value of the AFS System
Devices

HSMN NewsFeed - 4 Feb 2010
Bioheart Launches First US FDA Approved Clinical Trial that Tests Gene-Modified Stem Cell Therapy in Patients with Congestive Heart Failure
Regenerative Medicine Cardiology

HSMN NewsFeed - 1 Feb 2010
Cephalon, Inc. Announces Agreement to Acquire Mepha AG
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 20 Jan 2010
Gambro Announces Agreement to Acquire CHF Solutions, Inc.
Devices Mergers & Acquisitions

HSMN NewsFeed - 5 Jan 2010
Bioheart Inks Deals with Distributors to Introduce Home Heart Failure Monitoring Systems Throughout the U.S.
Devices Cardiology Monitoring Distribution

HSMN NewsFeed - 29 Oct 2009
Activaero Closes a 10.7 Million ($16 million) Series A Financing
Devices Drug Delivery Venture Capital

HSMN NewsFeed - 26 Oct 2009
New Data Presented From WELCOME Trial Show Positive Impact of CIMZIA(R) (certolizumab pegol) on Hospitalizations and Surgeries in Patients With Prior Infliximab Failure
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 19 Oct 2009
FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and Twynsta(R) as New Combination Treatment for High Blood Pressure
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 8 Oct 2009
BMEYE B.V. Completes EUR 6 Million Series B Financing Round
Devices Monitoring Venture Capital

HSMN NewsFeed - 6 Oct 2009
SIMPONI(TM) (golimumab) Receives European Approval as Once-Monthly Subcutaneous Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis with Novel SmartJect(TM) Autoinjector
Biopharmaceuticals Regulatory

HSMN NewsFeed - 9 Sep 2009
New Chief Executive Officer and Vice President Commercial Operations USA at the Helsinn Group's American subsidiary, Helsinn Therapeutics (U.S.) Inc.
Biopharmaceuticals Personnel

HSMN NewsFeed - 2 Sep 2009
Cardiola Penetrates European Market with Its Muscular CounterPulsation (MCP)-based m.pulse(R) system
Devices Cardiology

HSMN NewsFeed - 18 Aug 2009
Avastin Plus Commonly Used Chemotherapies Improved Progression-Free Survival (PFS) in Women with Previously Treated Advanced Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 26 Jun 2009
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 1 Jun 2009
Cimzia(R) (certolizumab pegol) Provides Long-Term Remission and Response Rates in Infliximab-Refractory Crohn's Patients
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 21 May 2009
FDA Approves SAMSCA(TM) (tolvaptan), the First and Only Oral Vasopressin Antagonist to Treat Patients With Clinically Significant Hypervolemic and Euvolemic Hyponatremia
Biopharmaceuticals FDA

HSMN NewsFeed - 13 May 2009
UCB's CIMZIA(R) (certolizumab pegol) Approved by the U.S. FDA for Adult Patients Suffering From Moderate to Severe Rheumatoid Arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 14 Apr 2009
Symphony Medical Announces First Patient Successfully Treated With Novel Congestive Heart Failure Therapy
Devices Cardiology

HSMN NewsFeed - 8 Apr 2009
Neurosurgeons from around the world gather at PLA 301 Hospital in China
Devices Surgery Neurosurgery Radiology

HSMN NewsFeed - 31 Mar 2009
GE Healthcare Announces Data from Phase III Study of AdreView in Heart Failure Patients
Biopharmaceuticals Cardiology Radiology

HSMN NewsFeed - 26 Mar 2009
Cardima Appoints DKSH Healthcare to Distribute its Surgical Ablation System and EP Products in Thailand
Devices Cardiology Distribution

HSMN NewsFeed - 24 Mar 2009
Myriad Applauds New ACOG Guidelines for Hereditary Breast and Ovarian Cancer
Diagnostics Oncology

HSMN NewsFeed - 9 Mar 2009
Cardium's InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
Devices Urology Oncology

HSMN NewsFeed - 5 Mar 2009
GlycoVaxyn AG Raises CHF 25 Million in Financing Led by Edmond de Rothschild Investment Partners
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 4 Mar 2009
Ferring Pharmaceuticals Announces Immediate Availability of Degarelix for the Treatment of Advanced Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 23 Feb 2009
AstraZeneca Announces SEROQUEL XR is Now Available to Treat Bipolar Depression
Biopharmaceuticals

HSMN NewsFeed - 17 Feb 2009
Break-through Drug for Heart Failure in Dogs Now Available in the United States
Biopharmaceuticals Cardiology

HSMN NewsFeed - 28 Jan 2009
Helsinn Announces the Acquisition of Sapphire Therapeutics Inc., USA to Establish Helsinn Therapeutics (US) Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 26 Jan 2009
Nonin Medical, Inc. Makes History With the First Continua(TM) Certified Product
Devices Monitoring

HSMN NewsFeed - 16 Dec 2008
Cardium's InnerCool Announces First Patient Treated With New Tissue-Specific UroCool(TM) System in Robotic-Assisted Prostate Surgery Study
Devices Urology

HSMN NewsFeed - 10 Dec 2008
Diagnoplex Closes CHF10 Million ($8.3 Million) Series A Financing
Diagnostics Oncology Venture Capital

HSMN NewsFeed - 11 Nov 2008
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
Devices Urology

HSMN NewsFeed - 27 Oct 2008
CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
Biopharmaceuticals

HSMN NewsFeed - 21 Oct 2008
Abbott's HUMIRA(R) (adalimumab) Data Shows Fistula Healing for Up to Three Years in Patients with Moderate to Severe Crohn's Disease
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 10 Oct 2008
FDA Approves AstraZeneca's SEROQUEL XR(R) for the Treatment of Bipolar Depression and Bipolar Mania
Biopharmaceuticals FDA

HSMN NewsFeed - 6 Oct 2008
CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohn's Patients
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 30 Sep 2008
Bioheart Announces 35 Leading U.S. Heart Failure Centers Engaged in Phase II/III Marvel Trial of Myogenic Cells for Treating Advanced Heart Failure
Regenerative Medicine Cardiology

HSMN NewsFeed - 18 Sep 2008
Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment
Biopharmaceuticals Dermatology

HSMN NewsFeed - 9 Sep 2008
MiCardia Corporation Receives US FDA Market Clearance For Dynaplasty(TM) Annuloplasty Devices
Devices Cardiology FDA

HSMN NewsFeed - 3 Sep 2008
Osprey Pharmaceuticals U.S.A., Inc. Completes $11 Million Initial Private Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 18 Aug 2008
Kevin Van Bladel Joins BioVentrix as Vice President of Research and Development
Devices Cardiology Personnel

HSMN NewsFeed - 7 Aug 2008
ESBATech Raises Additional CHF 23M (USD 22M), Extending Series B Venture Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 14 Jul 2008
FDA Updates Label for AVANDIA(R) to Include Clinical Findings Demonstrating Sustained Glycemic Control for Up to Five Years
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 11 Jul 2008
Bioheart, Inc. to Introduce At-Home Heart Failure Monitor for Congestive Heart Failure Patients
Devices Monitoring Cardiology

HSMN NewsFeed - 7 Jul 2008
Medtronic Starts International Market Launch and U.S. Clinical Trial of Endurant Stent Graft
Devices Interventional

HSMN NewsFeed - 13 Jun 2008
Data Show that Abbott's HUMIRA(R) (adalimumab) Reduced the Signs and Symptoms of Ankylosing Spondylitis Up to Three Years
Biopharmaceuticals

HSMN NewsFeed - 13 Jun 2008
HUMIRA(R) (adalimumab) Data Show That Treating Early Rheumatoid Arthritis With Combination Treatment Resulted in Cost Savings From Improved Work Productivity
Biopharmaceuticals

HSMN NewsFeed - 13 Jun 2008
New Long-Term HUMIRA(R) (adalimumab) Data Show Up to Seven-Year Efficacy with Combination Treatment for Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 2 Jun 2008
MethylGene Reports Clinical Data for MGCD0103 at the 44th American Society of Clinical Oncology (ASCO) Annual Meeting
Biopharmaceuticals Oncology

HSMN NewsFeed - 21 May 2008
Abbott Presents Long-Term Data From Extension Study Showing Adult Crohn's Patients Treated With HUMIRA(R) (Adalimumab) Maintained Remission
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 20 May 2008
Newly-Approved Cimzia(R) Provides Rapid, Sustained Response in Crohn's Patients
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 20 May 2008
GlycoVaxyn Appoints Philippe Dro as CEO
Biopharmaceuticals Personnel

HSMN NewsFeed - 19 May 2008
Bayer Announces Availability of Reformulated Liquid Leukine(R)
Biopharmaceuticals FDA

HSMN NewsFeed - 14 May 2008
FDA Approves AstraZeneca's Seroquel(R) for Maintenance Treatment in Bipolar Disorder
Biopharmaceuticals FDA

HSMN NewsFeed - 18 Apr 2008
Genomics Likely to Replace Traditional Drug Therapies in Treating CHF
Biopharmaceuticals Cardiology

HSMN NewsFeed - 16 Apr 2008
Abbott Announces HUMIRA(R) (adalimumab) Approved in Japan for the Treatment of Rheumatoid Arthritis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 14 Apr 2008
Jazz Pharmaceuticals' LUVOX CR Is Now Available for Patients With Social Anxiety Disorder (SAD) and Obsessive Compulsive Disorder (OCD)
Biopharmaceuticals

HSMN NewsFeed - 8 Apr 2008
Advancing Interoperability - Nonin(R) Medical Unveils World's First Bluetooth(R)-Enabled, Wireless Fingertip Pulse Oximeter
Devices Monitoring

HSMN NewsFeed - 1 Apr 2008
SPP100 (Tekturna/Rasilez) Reduces Left Ventricular Hypertrophy
Biopharmaceuticals Cardiology

HSMN NewsFeed - 31 Mar 2008
New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes
Biopharmaceuticals Cardiology Endocrinology

HSMN NewsFeed - 19 Mar 2008
New Study Backs use of Gene-Based Urine Test in Prostate Cancer
Diagnostics Oncology Urology

HSMN NewsFeed - 29 Feb 2008
AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder
Biopharmaceuticals

HSMN NewsFeed - 27 Feb 2008
IsoRay Appoints New Chairman and Interim CEO and Announces Management Changes upon Incumbent Resignation
Devices Personnel

HSMN NewsFeed - 22 Feb 2008
Abbott Receives FDA Approval for HUMIRA(R) (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis
Biopharmaceuticals FDA

HSMN NewsFeed - 5 Feb 2008
Mitralign Successfully Completes First Human Case
Devices Interventional Cardiology

HSMN NewsFeed - 22 Jan 2008
Roche to Acquire Ventana for $89.50 per share
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 21 Jan 2008
US Approval for SPP100 Combined with Diuretic to Treat Hypertension
Biopharmaceuticals FDA

HSMN NewsFeed - 19 Jan 2008
Abbott's HUMIRA(R) (adalimumab) Receives FDA Approval For Moderate to Severe Chronic Plaque Psoriasis
Biopharmaceuticals FDA

HSMN NewsFeed - 17 Jan 2008
Angiotech and Symphony Medical Announce Licensing Agreement
Devices Cardiology Licensing

HSMN NewsFeed - 8 Jan 2008
Journal of Urology Supplement Focuses on Focal Therapy as a Prostate Cancer Treatment
Devices Urology Oncology

HSMN NewsFeed - 20 Dec 2007
Abbott's HUMIRA(R) Approved in the European Union for Treatment of Moderate-to-Severe Plaque Psoriasis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 11 Dec 2007
GlaxoSmithKline Responds to JAMA Article on the ICES Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes
Biopharmaceuticals Endocrinology Cardiology

HSMN NewsFeed - 4 Dec 2007
PregLem SA Announces CHF 36 Million Series B Funding and New Licencing Agreement With HRA Pharma
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 3 Dec 2007
Mitralign(R) Announces Closing of Series C Financing
Devices Interventional Cardiology Venture Capital

HSMN NewsFeed - 20 Nov 2007
EarlySense Receives FDA Clearance for Its Contact-Free Patient's Clinical Status Monitor
Devices Monitoring FDA

HSMN NewsFeed - 16 Nov 2007
Abbott's HUMIRA(R) Receives Positive Opinion From EMEA for Treatment of Moderate to Severe Plaque Psoriasis
Biopharmaceuticals Regulatory

HSMN NewsFeed - 12 Nov 2007
Actelion: Pivlaz (Clazosentan) Phase III Study Initiated to Demonstrate Prevention of Vasospasm-Related Morbidity and All-Cause Mortality After Aneurysmal Subarachnoid Hemorrhage
Biopharmaceuticals Neurosurgery

HSMN NewsFeed - 8 Nov 2007
Abbott Study Examines Rates of Uveitis (Inflammation of the Eye) in Ankylosing Spondylitis Patients Treated with HUMIRA(R) (adalimumab)
Biopharmaceuticals

HSMN NewsFeed - 16 Oct 2007
ViRexx Announces Second OvaRex(R) MAb Phase III Trial Reaches 118th Relapse Event
Biopharmaceuticals Oncology

HSMN NewsFeed - 16 Oct 2007
BioVentrix Loses Round One in Patent Infringement Trial
Devices Cardiology Litigation

HSMN NewsFeed - 10 Oct 2007
Multicenter PolyHeme Trauma Study Presented at the American College of Surgeons 93rd Annual Clinical Congress
Biopharmaceuticals

HSMN NewsFeed - 2 Oct 2007
Cardiac Stem Cell Therapy Company, Cardio3 BioSciences, Appoints Patrick Jeanmart as Its Chief Financial Officer (CFO)
Regenerative Medicine Cardiology Personnel

HSMN NewsFeed - 1 Oct 2007
bioMerieux Launches VIDAS(R) NT-proBNP, an Aid for Diagnosis and Prognosis of Heart Failure
Diagnostics Cardiology Regulatory

HSMN NewsFeed - 24 Sep 2007
ARIAD Initiates Phase 3 'Succeed' Trial of Oral Deforolimus in Patients with Metastatic Sarcomas
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Sep 2007
Cardiac Stem Cell Therapy Company, Cardio3 BioSciences, Appoints Former New Jersey Medical School Assistant Professor, Dr. Vinciane Gaussin, as its Chief Scientific Officer (CSO)
Regenerative Medicine Cardiology Personnel

HSMN NewsFeed - 10 Sep 2007
Medtronic Makes Equity Investment in NanoCor Therapeutics, Inc.
Biopharmaceuticals Cardiology

HSMN NewsFeed - 10 Sep 2007
Myriad Genetics Launches Awareness Advertising Campaign to Educate Women About Hereditary Risks of Breast and Ovarian Cancers
Diagnostics Oncology

HSMN NewsFeed - 4 Sep 2007
Encysive Pharmaceuticals Announces Completion of Patient Enrollment in Phase II Diastolic Heart Failure Trial
Biopharmaceuticals Cardiology

HSMN NewsFeed - 28 Aug 2007
Aspreva and Roche Update CellCept Agreement
Biopharmaceuticals

HSMN NewsFeed - 27 Aug 2007
SPP100 (Rasilez) Receives EU Approval
Biopharmaceuticals Regulatory

HSMN NewsFeed - 21 Aug 2007
Roche Extends Tender Offer for Ventana
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 14 Aug 2007
GlaxoSmithKline Updates Prescribing Information for Avandia
Biopharmaceuticals Endocrinology Cardiology FDA

HSMN NewsFeed - 26 Jul 2007
Roche Extends Tender Offer for Ventana
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 26 Jul 2007
Myriad Genetics Launches New Molecular Diagnostic Test
Diagnostics Oncology

HSMN NewsFeed - 25 Jul 2007
Roche Announces Expiration of HSR Waiting Period for Ventana Offer
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 25 Jul 2007
Merck & Co., Inc. to Acquire NovaCardia, Inc., to Boost Clinical Pipeline of Cardiovascular Drug Candidates
Biopharmaceuticals Cardiology Mergers & Acquisitions

HSMN NewsFeed - 11 Jul 2007
Roche Says Offer for Ventana Medical Systems, Inc. is Full and Fair
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 27 Jun 2007
Roche Commences Tender Offer for Ventana for $75 Per Share in Cash
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 25 Jun 2007
Roche Makes Offer to Acquire Ventana for $75.00 Per Share in Cash
Diagnostics Mergers & Acquisitions

HSMN NewsFeed - 21 Jun 2007
Vasomedical Announces a New Strategic Alliance with Living Data Technology Corp.
Devices Cardiology

HSMN NewsFeed - 19 Jun 2007
Myriad Genetics Collaborates With AstraZeneca on Phase 2 Trials
Biopharmaceuticals Oncology

HSMN NewsFeed - 19 Jun 2007
New Study Demonstrates Significant Economic and Clinical Value of NT-proBNP Testing for the Management of Heart Failure
Diagnostics Cardiology

HSMN NewsFeed - 18 Jun 2007
Basilea Announces Submission of Marketing Authorization Application in Europe by Janssen-Cilag International NV for Ceftobiprole, a Novel Anti-MRSA Broad-spectrum Cephalosporin
Biopharmaceuticals Regulatory

HSMN NewsFeed - 15 Jun 2007
Three Studies Suggest Abbott's HUMIRA(R) (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
Biopharmaceuticals

HSMN NewsFeed - 12 Jun 2007
Response Biomedical Receives Approval to Market NT-proBNP Congestive Heart Failure Marker Test in Canada
Diagnostics Cardiology Regulatory

HSMN NewsFeed - 11 Jun 2007
Pilot Phase 3 Results of NovaCardia's KW-3902 for Acute Congestive Heart Failure Presented at Late-Breaking Session of Heart Failure Congress 2007
Biopharmaceuticals Cardiology

HSMN NewsFeed - 7 Jun 2007
Abbott's HUMIRA(R) (Adalimumab) Approved in the European Union for the Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 6 Jun 2007
Takeda Revises ACTOS(R) (pioglitazone HCl) Prescribing Label
Biopharmaceuticals Endocrinology FDA

HSMN NewsFeed - 4 Jun 2007
Updated Overall Survival Data From Pivotal Herceptin Adjuvant Studies in HER2-Positive Breast Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 22 May 2007
Orqis(R) Medical's MOMENTUM Pivotal Trial Nears Enrollment Completion
Devices Cardiology

HSMN NewsFeed - 22 May 2007
New Analysis of Data Shows Treatment With Abbott's HUMIRA(R) (Adalimumab) Significantly Reduced Disease-Related Hospitalization for Patients with Crohn's Disease
Biopharmaceuticals Gastroenterology

HSMN NewsFeed - 7 May 2007
Abbott Seeks U.S. and E.U. Regulatory Approvals for HUMIRA(R) (Adalimumab) as a Treatment for Juvenile Rheumatoid Arthritis
Biopharmaceuticals FDA Regulatory

HSMN NewsFeed - 27 Apr 2007
Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion from European Medicines Agency for the Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology Regulatory

HSMN NewsFeed - 12 Apr 2007
Data Analyses Outline Efficacy and Safety of MIRCERA(TM) for the Treatment of Renal Anemia Associated With Chronic Kidney Disease
Biopharmaceuticals

HSMN NewsFeed - 10 Apr 2007
Mitralign Announces an Additional Medical Director in Advance of Clinical Pilot Study
Devices Interventional Cardiology Personnel

HSMN NewsFeed - 10 Apr 2007
Abbott Opens New Biotechnology Manufacturing Facility in Puerto Rico
Biopharmaceuticals

HSMN NewsFeed - 2 Apr 2007
Abbott Seeks U.S. and E.U. Regulatory Approval for HUMIRA(R) (Adalimumab) in Psoriasis
Biopharmaceuticals Dermatology FDA

HSMN NewsFeed - 12 Mar 2007
Smith & Nephew plc Announces Acquisition
Devices Orthopaedic Mergers & Acquisitions

HSMN NewsFeed - 9 Mar 2007
Baxter Initiates Multi-Center Phase II Clinical Trial to Manage Fluid Overload in Congestive Heart Failure Patients
Biopharmaceuticals Cardiology

HSMN NewsFeed - 5 Mar 2007
Medtronic Submits Pre-Market Approval Application to the FDA for the Talent(TM) Thoracic Stent Graft System
Devices Interventional

HSMN NewsFeed - 28 Feb 2007
Hana Biosciences Appoints Lyn Wiesinger to Board of Directors
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 27 Feb 2007
HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of Crohn's Disease
Biopharmaceuticals Gastroenterology FDA

HSMN NewsFeed - 6 Feb 2007
Study Showing Benefits of Ultrafiltration Therapy for Heart Failure Patients Published in Journal of American College of Cardiology
Devices Cardiology

HSMN NewsFeed - 30 Jan 2007
Statins Can Slow Progression of Aortic Valve Disease
Biopharmaceuticals Cardiology

HSMN NewsFeed - 22 Jan 2007
Zecotek Announces Board and Management Changes
Devices Personnel

HSMN NewsFeed - 15 Jan 2007
4-Antibody AG Closes CHF 17 Million Series A Financing, Bringing the Total Series A Financing to CHF 23 Million ($ 18.5Million)
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 5 Jan 2007
Merck KGaA Acquires Majority Shareholding in Serono S.A.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 14 Dec 2006
New Data On Pfizer's Aromasin and Ellence to Be Presented at San Antonio Breast Cancer Symposium
Biopharmaceuticals Oncology

HSMN NewsFeed - 14 Dec 2006
Response Biomedical Files for US FDA 510k Market Clearance of RAMP NT-proBNP Test for the Diagnosis of Congestive Heart Failure
Diagnostics Cardiology FDA

HSMN NewsFeed - 6 Dec 2006
Cardioxyl Pharmaceuticals Closes $14.5M Series A Financing
Biopharmaceuticals Venture Capital

HSMN NewsFeed - 4 Dec 2006
Landmark Study Shows Avandia(R) (rosiglitazone maleate) Is More Effective Than Metformin or a Sulfonylurea in Long-Term Blood Sugar Control in Type 2 Diabetes
Biopharmaceuticals Endocrinology

HSMN NewsFeed - 20 Nov 2006
Orqis(R) Medical Reaches MOMENTUM Pivotal Trial Mid-Point with 100th Patient Enrollment
Devices Cardiology

HSMN NewsFeed - 20 Nov 2006
Actelion Announces Definitive Agreement to Acquire U.S.-Based CoTherix, Inc.
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 16 Nov 2006
FDA Approves Herceptin(R) for the Adjuvant Treatment of HER2-Positive Node-Positive Breast Cancer
Biopharmaceuticals Oncology FDA

HSMN NewsFeed - 14 Nov 2006
NovaCardia Presents Phase II Data for KW-3902 at American Heart Association's 79th Annual Scientific Sessions
Biopharmaceuticals Cardiology

HSMN NewsFeed - 14 Nov 2006
Sorin Group Initiates Multi-Center 'OPTION' Study in Europe
Devices Cardiology

HSMN NewsFeed - 7 Nov 2006
Mitralign Shines at TCT 2006; Performs Live Case & Reveals Clinical Strategy
Devices Interventional Cardiology

HSMN NewsFeed - 6 Nov 2006
IsoTis Proposes to Become a U.S. Company With a Single NASDAQ Listing in Q1 2007
Devices

HSMN NewsFeed - 3 Nov 2006
AGA Medical and Ample Medical to Collaborate on the Development of Innovative Treatment for Congestive Heart Failure
Devices Cardiology

HSMN NewsFeed - 1 Nov 2006
Cellgate Commences Phase II Clinical Trial of Anticancer Compound CGC-11047 for Prostate Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 31 Oct 2006
Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology

HSMN NewsFeed - 24 Oct 2006
Myriad Genetics Sponsors Clinical Trial in Pancreatic Cancer
Biopharmaceuticals Oncology

HSMN NewsFeed - 20 Oct 2006
FDA Approves AstraZeneca's SEROQUEL(R) For Bipolar Depression Treatment
Biopharmaceuticals FDA

HSMN NewsFeed - 16 Oct 2006
Serono and Newron Announce Global Development and Commercialization Agreement for Safinamide
Biopharmaceuticals Neurology Licensing

HSMN NewsFeed - 5 Oct 2006
New Phase III Data Show Abbott's HUMIRA(R) (Adalimumab) Was Statistically Superior to Methotrexate in Patients With Psoriasis
Biopharmaceuticals

HSMN NewsFeed - 28 Sep 2006
Published Study Shows Focal Cryoablation Effective in Destroying Prostate Cancer, Preserving Potency, Continence
Devices Oncology

HSMN NewsFeed - 25 Sep 2006
NovaCardia Raises $48 Million in Series B
Biopharmaceuticals Cardiology Venture Capital

HSMN NewsFeed - 21 Sep 2006
MiCardia Corporation Completes $9 Million Private Financing
Devices Cardiology Venture Capital

HSMN NewsFeed - 21 Sep 2006
Merck KgaA to Acquire Serono
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 13 Sep 2006
Impulse Dynamics Announces New Data Regarding Its Optimizer System Utilizing Cardiac Contractility Modulation (CCM) Technology
Devices Cardiology

HSMN NewsFeed - 7 Sep 2006
Omeros Acquires Nura
Biopharmaceuticals Mergers & Acquisitions

HSMN NewsFeed - 24 Jul 2006
Response Biomedical Completes US Distribution Network For RAMP Cardiovascular Products
Diagnostics Cardiology Distribution

HSMN NewsFeed - 13 Jul 2006
CoGenesys Receives FDA Clearance to Commence Clinical Trials of Cardeva in Patients with Chronic Heart Failure
Biopharmaceuticals Cardiology FDA

HSMN NewsFeed - 6 Jul 2006
First Human Implants of Ample Medical's PS3 System(TM)
Devices Interventional Cardiology

HSMN NewsFeed - 23 Jun 2006
New Phase III Data Demonstrate That Abbott's HUMIRA(R) (Adalimumab) Sustained Reduction in Signs and Symptoms Through One Year in Patients With Ankylosing Spondylitis
Biopharmaceuticals

HSMN NewsFeed - 29 May 2006
Zecotek Medical Systems announces new management, scientific advisory board appointments, and website release
Devices Personnel

HSMN NewsFeed - 24 May 2006
Clinical Trial Tests Effect of Ultrasound Waves on Early-Stage Prostate Cancer
Devices Oncology Urology

HSMN NewsFeed - 22 May 2006
New Data Presented on the Effect of Cymbalta(R) on Sexual Function in Depressed Patients
Biopharmaceuticals

HSMN NewsFeed - 19 May 2006
BIOTRONIK Announces Food and Drug Administration Approvable Status for Revolutionary Heart Failure Therapy System
Devices Cardiology FDA

HSMN NewsFeed - 17 May 2006
New Phase III Data on Renin Inhibitor SPP100 (Rasilez) in Treatment of Hypertension Demonstrates Potential of This First-in-Class Drug
Biopharmaceuticals

HSMN NewsFeed - 15 May 2006
Response Biomedical and Shionogi Finalize Commercialization Agreement For RAMP Cardiovascular Testing in Japan
Diagnostics Cardiology

Return to NewsFeed

Additional items found! 228

Members: click here for search results from The HSMN Archive (password required)

Members Archive contains 228 additional stories matching:
CHF
(Password required)

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!